Nilutamide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 216 publications
Interstitial lung disease associated with antiandrogen agents: a pharmacovigilance study based on FDA adverse event reporting system.
Journal: International urology and nephrology
Published: March 17, 2026
Exploring the interplay of electron density distribution and electrostatic potential in the interaction of nilutamide and flutamide with androgen receptors using quantum crystallography.
Journal: RSC advances
Published: October 07, 2025
Nanoengineered scheelite-structured SrWO4 decorated on MXene sheets: A novel platform for electrochemical sensing of the anti-cancer drug nilutamide with DFT insights.
Journal: Environmental research
Published: July 12, 2025
Polymorphic Control in Pharmaceutical Gel-Mediated Crystallization: Exploiting Solvent-Gelator Synergy in FmocFF Organogels.
Journal: Gels (Basel, Switzerland)
Published: June 10, 2025
Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: May 16, 2025
3D Nanoflowers of Binary Metal-Selenide for Improved Electrochemical Sensing and High-Energy-Density Energy Storage.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: May 15, 2025
Assessing novel analogues of nilutamide as a human androgen receptor antagonist: A detailed investigation of drug design using a bioisosteric methodology including ADMET profiling, molecular docking studies and molecular dynamics simulation.
Journal: Computational biology and chemistry
Published: December 31, 2024
Single-Dose Drug Development Candidate for Schistosomiasis.
Journal: ACS infectious diseases
Published: October 18, 2024
Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells.
Journal: Open medicine (Warsaw, Poland)
Published: August 28, 2024
Recent Development in Hydantoins, Thiohydantoins, and Selenohydantoins as Anticancer Agents: Structure-activity Relationship and Design Strategies.
Journal: Mini reviews in medicinal chemistry
Published: May 09, 2024
Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancer.
Journal: The Prostate
Published: January 09, 2024
Targeting AR-positive breast cancer cells via drug repurposing approach.
Journal: Computational biology and chemistry
Published: October 02, 2023
Last Updated: 06/30/2026